Vaccitech induces T cells and antibodies to treat and prevent disease
Learn More
prevent disease


people worldwide

life at vaccitech
Our Mission

Image: NIAID
Treating and Preventing Disease
We develop T cell immunotherapeutic products and vaccines to improve global health
Vaccitech is a spin-out company from the University of Oxford’s Jenner Institute, one of the most prestigious vaccine research centres in the world.












OUR APPROACH
Teaching the immune system to confront deadly infections
Traditional vaccine technology creates a pronounced antibody response to the infectious agent. Vaccitech’s platform is able to also induce potent and durable T cell responses from the cellular arm of the immune system.